Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 119 results found. Search for [ Adar Poonawalla coronavirus vaccine ]

Results 1 to 21 of 119
BusinessToday.In
October 30, 2020
Measures such as consistent ventilation, disinfection of surfaces, wearing of face masks, and ample social distancing while boarding and deboarding the plane can mitigate transmission risks on flights, it said


BusinessToday.In
New Delhi, October 29, 2020
Oxford and AstraZeneca's COVID-19 vaccine trials in India are expected to be over by January, said Serum Institute of India (SII) CEO Adar Poonawalla. Sharing details of the final stage of the trial, Poonawalla said that his company had already given the first dose to more than 1,000 patients. He added that the vaccine is producing a good immune response in addition to antibodies and would be up to the UK and Indian health authorities to take a decision on how safe and effective it is. Watch the video for more.Also Read: COVID-19 vaccine: Dr Reddy's aims to wind up Phase-3 trials of Sputnik V by March 2021


BusinessToday.In
October 29, 2020
PM Modi says India has emerged as a friendly country in terms of investment, which is evident in foreign direct investment numbers; India has made steady recovery in manufacturing too, he adds


BusinessToday.In
October 29, 2020
PM Modi says despite the fact that the country's plans were shattered by the pandemic, it'll try and run faster next year to make up for the losses in the current year


BusinessToday.In
October 29, 2020
Coronavirus vaccine: PM Modi said that a digital platform is being created now that will eventually help in enrolling, tracking and reaching beneficiaries


Reuters
October 29, 2020
India and China, which fought a brief but bloody border war in 1962, are currently locked in a military stand-off along their contested Himalayan border that includes the region of Ladakh in question


BusinessToday.In
October 29, 2020
Adar Poonawalla claimed there was no immediate concern about the safety of the Oxford vaccine, adding that early indicators have been positive. However, Poonawalla said it will take a year or two to be certain that the vaccine has long-term effect


BusinessToday.In
October 23, 2020
The funds provisioned, so far are for the current financial year ending March 31, and going further, there will be no shortage of them for this purpose


PB Jayakumar
October 22, 2020
Serum Institute of India (SII) has teamed up with Merck KGaA, Germany, to develop COVID-19 fighting monoclonal antibodies (mAbs), made by cloning a unique white blood cell to increase immunity and fight diseases, along with drug research driven nonprofit scientific research organization IAVI and Scripps Research


PB Jayakumar & Joe C Mathew
October 22, 2020
There is not a single instance in history of a vaccine that has been discontinued


BusinessToday.In
October 11, 2020
PM Modi to launch SVAMITVA scheme: It will be implemented in a phased manner over four years and will eventually cover 6.62 lakh villages across the country


BusinessToday.In
October 8, 2020
Future cost of the COVID-19 vaccine could become a contentious issue. Some pharma companies have said they can't produce vaccine on a non-profit basis, while others like AstraZeneca and Johnson & Johnson will provide doses on a \"cost basis\" during COVID-19 pandemic


BusinessToday.In
October 3, 2020
COVID-19 vaccine: A principal investigator from a trial site in Maharashtra said that they are expecting to finish enrolling the participants within the next two months after which they will be monitored for the vaccine's efficacy


BusinessToday.In
October 1, 2020
The scientists believe that these genes still persist because they were once beneficial -- perhaps to fight off other infections


Reuters
September 30, 2020
GSK is contributing adjuvants, efficacy boosters that play a vital role in many vaccines, in several development alliances for potential future vaccines against the novel coronavirus that has claimed more than a million lives globally


BusinessToday.In
September 30, 2020
COVID-19 vaccine being developed by AstraZeneca-Oxford University, Novavax, Moderna, Pfizer Inc and Johnson & Johnson are already in an advanced stage of testing


Reuters
September 30, 2020
Global competition for early coronavirus vaccine doses is already fierce, months ahead of any approvals, as wealthy countries move to secure supplies


BusinessToday.In
September 30, 2020
The clarification came from Union Health Secretary Rajesh Bhushan when he was asked for a response about Poonawalla's tweet highlighting issues in coronavirus vaccine production and distribution in India


PB Jayakumar
September 29, 2020
The vaccines will have a ceiling price of US$3 per dose, thanks to investments made by partners such as the Coalition for Epidemic Preparedness Innovations (CEPI) and the Bill & Melinda Gates Foundation


BusinessToday.In
September 29, 2020
Coronavirus vaccine: In August, the SII entered into a partnership with Gavi (Global Alliance for Vaccines and Immunisation), and Bill & Melinda Gates Foundation to produce 100 million (10 crore) doses for India and LMICs


PAGES 1 OF 6  12345